Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other top dividend ...
Pfizer (NYSE:PFE) is currently dealing with shareholder proposals concerning governance issues such as religious ...
The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...
After learning doctors weren’t prescrbing its migraine drug Nurtec because they assumed insurance coverage would be a hassle, the company ...
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Pfizer offers a 6.7% dividend yield, trading at a low valuation with resilient drug portfolio growth. Realty Income Corp. has ...
Pfizer (NYSE:PFE) stock and Arvinas (NASDAQ:ARVN) stock slip in reaction to mixed Phase 3 data for their breast cancer drug ...
3d
Zacks.com on MSNPfizer (PFE) Stock Moves -0.43%: What You Should KnowThe latest trading day saw Pfizer (PFE) settling at $25.60, representing a -0.43% change from its previous close.
Pfizer (NYSE:PFE) announced positive outcomes from the Phase 3 VERITAC-2 clinical trial, showing vepdegestrant's promise in ...
Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...
Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...
Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results